Global G-CSF Injection Market Growth 2026-2032
The global G-CSF Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key G-CSF Injection players cover Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “G-CSF Injection Industry Forecast” looks at past sales and reviews total world G-CSF Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected G-CSF Injection sales for 2026 through 2032. With G-CSF Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-CSF Injection industry.
This Insight Report provides a comprehensive analysis of the global G-CSF Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on G-CSF Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global G-CSF Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-CSF Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-CSF Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of G-CSF Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for G-CSF Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key G-CSF Injection players cover Amgen Inc., Pfizer, Sandoz (Novartis), Spectrum Pharmaceuticals, Biocon Biologics Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “G-CSF Injection Industry Forecast” looks at past sales and reviews total world G-CSF Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected G-CSF Injection sales for 2026 through 2032. With G-CSF Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-CSF Injection industry.
This Insight Report provides a comprehensive analysis of the global G-CSF Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on G-CSF Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global G-CSF Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-CSF Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-CSF Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of G-CSF Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-acting G-CSF Injection
- Short-acting G-CSF Injection
- Neoplastic Diseases
- Blood Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Pfizer
- Sandoz (Novartis)
- Spectrum Pharmaceuticals
- Biocon Biologics Inc.
- Coherus BioSciences, Inc.
- Teva Pharmaceutical
- Sanofi
- Yifan Pharmaceutical
- CSPC
- Jiangsu Hengrui Medicine
- Qilu Pharmaceutical
- Shan Dong Kexing Biopharm
- What is the 10-year outlook for the global G-CSF Injection market?
- What factors are driving G-CSF Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do G-CSF Injection market opportunities vary by end market size?
- How does G-CSF Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global G-CSF Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for G-CSF Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for G-CSF Injection by Country/Region, 2021, 2025 & 2032
2.2 G-CSF Injection Segment by Type
2.2.1 Long-acting G-CSF Injection
2.2.2 Short-acting G-CSF Injection
2.2.3 G-CSF Injection Sales by Type
2.2.3.1 Global G-CSF Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global G-CSF Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global G-CSF Injection Sale Price by Type (2021-2026)
2.3 G-CSF Injection Segment by Application
2.3.1 Neoplastic Diseases
2.3.2 Blood Disorders
2.3.3 Others
2.3.4 G-CSF Injection Sales by Application
2.3.4.1 Global G-CSF Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global G-CSF Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global G-CSF Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global G-CSF Injection Breakdown Data by Company
3.1.1 Global G-CSF Injection Annual Sales by Company (2021-2026)
3.1.2 Global G-CSF Injection Sales Market Share by Company (2021-2026)
3.2 Global G-CSF Injection Annual Revenue by Company (2021-2026)
3.2.1 Global G-CSF Injection Revenue by Company (2021-2026)
3.2.2 Global G-CSF Injection Revenue Market Share by Company (2021-2026)
3.3 Global G-CSF Injection Sale Price by Company
3.4 Key Manufacturers G-CSF Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers G-CSF Injection Product Location Distribution
3.4.2 Players G-CSF Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR G-CSF INJECTION BY GEOGRAPHIC REGION
4.1 World Historic G-CSF Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global G-CSF Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global G-CSF Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic G-CSF Injection Market Size by Country/Region (2021-2026)
4.2.1 Global G-CSF Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global G-CSF Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas G-CSF Injection Sales Growth
4.4 APAC G-CSF Injection Sales Growth
4.5 Europe G-CSF Injection Sales Growth
4.6 Middle East & Africa G-CSF Injection Sales Growth
5 AMERICAS
5.1 Americas G-CSF Injection Sales by Country
5.1.1 Americas G-CSF Injection Sales by Country (2021-2026)
5.1.2 Americas G-CSF Injection Revenue by Country (2021-2026)
5.2 Americas G-CSF Injection Sales by Type (2021-2026)
5.3 Americas G-CSF Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC G-CSF Injection Sales by Region
6.1.1 APAC G-CSF Injection Sales by Region (2021-2026)
6.1.2 APAC G-CSF Injection Revenue by Region (2021-2026)
6.2 APAC G-CSF Injection Sales by Type (2021-2026)
6.3 APAC G-CSF Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe G-CSF Injection by Country
7.1.1 Europe G-CSF Injection Sales by Country (2021-2026)
7.1.2 Europe G-CSF Injection Revenue by Country (2021-2026)
7.2 Europe G-CSF Injection Sales by Type (2021-2026)
7.3 Europe G-CSF Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa G-CSF Injection by Country
8.1.1 Middle East & Africa G-CSF Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa G-CSF Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa G-CSF Injection Sales by Type (2021-2026)
8.3 Middle East & Africa G-CSF Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of G-CSF Injection
10.3 Manufacturing Process Analysis of G-CSF Injection
10.4 Industry Chain Structure of G-CSF Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 G-CSF Injection Distributors
11.3 G-CSF Injection Customer
12 WORLD FORECAST REVIEW FOR G-CSF INJECTION BY GEOGRAPHIC REGION
12.1 Global G-CSF Injection Market Size Forecast by Region
12.1.1 Global G-CSF Injection Forecast by Region (2027-2032)
12.1.2 Global G-CSF Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global G-CSF Injection Forecast by Type (2027-2032)
12.7 Global G-CSF Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. G-CSF Injection Product Portfolios and Specifications
13.1.3 Amgen Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer G-CSF Injection Product Portfolios and Specifications
13.2.3 Pfizer G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sandoz (Novartis)
13.3.1 Sandoz (Novartis) Company Information
13.3.2 Sandoz (Novartis) G-CSF Injection Product Portfolios and Specifications
13.3.3 Sandoz (Novartis) G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sandoz (Novartis) Main Business Overview
13.3.5 Sandoz (Novartis) Latest Developments
13.4 Spectrum Pharmaceuticals
13.4.1 Spectrum Pharmaceuticals Company Information
13.4.2 Spectrum Pharmaceuticals G-CSF Injection Product Portfolios and Specifications
13.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Spectrum Pharmaceuticals Main Business Overview
13.4.5 Spectrum Pharmaceuticals Latest Developments
13.5 Biocon Biologics Inc.
13.5.1 Biocon Biologics Inc. Company Information
13.5.2 Biocon Biologics Inc. G-CSF Injection Product Portfolios and Specifications
13.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Biologics Inc. Main Business Overview
13.5.5 Biocon Biologics Inc. Latest Developments
13.6 Coherus BioSciences, Inc.
13.6.1 Coherus BioSciences, Inc. Company Information
13.6.2 Coherus BioSciences, Inc. G-CSF Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences, Inc. Main Business Overview
13.6.5 Coherus BioSciences, Inc. Latest Developments
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Information
13.7.2 Teva Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceutical Main Business Overview
13.7.5 Teva Pharmaceutical Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi G-CSF Injection Product Portfolios and Specifications
13.8.3 Sanofi G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Yifan Pharmaceutical
13.9.1 Yifan Pharmaceutical Company Information
13.9.2 Yifan Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yifan Pharmaceutical Main Business Overview
13.9.5 Yifan Pharmaceutical Latest Developments
13.10 CSPC
13.10.1 CSPC Company Information
13.10.2 CSPC G-CSF Injection Product Portfolios and Specifications
13.10.3 CSPC G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CSPC Main Business Overview
13.10.5 CSPC Latest Developments
13.11 Jiangsu Hengrui Medicine
13.11.1 Jiangsu Hengrui Medicine Company Information
13.11.2 Jiangsu Hengrui Medicine G-CSF Injection Product Portfolios and Specifications
13.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hengrui Medicine Main Business Overview
13.11.5 Jiangsu Hengrui Medicine Latest Developments
13.12 Qilu Pharmaceutical
13.12.1 Qilu Pharmaceutical Company Information
13.12.2 Qilu Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Qilu Pharmaceutical Main Business Overview
13.12.5 Qilu Pharmaceutical Latest Developments
13.13 Shan Dong Kexing Biopharm
13.13.1 Shan Dong Kexing Biopharm Company Information
13.13.2 Shan Dong Kexing Biopharm G-CSF Injection Product Portfolios and Specifications
13.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shan Dong Kexing Biopharm Main Business Overview
13.13.5 Shan Dong Kexing Biopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global G-CSF Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for G-CSF Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for G-CSF Injection by Country/Region, 2021, 2025 & 2032
2.2 G-CSF Injection Segment by Type
2.2.1 Long-acting G-CSF Injection
2.2.2 Short-acting G-CSF Injection
2.2.3 G-CSF Injection Sales by Type
2.2.3.1 Global G-CSF Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global G-CSF Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global G-CSF Injection Sale Price by Type (2021-2026)
2.3 G-CSF Injection Segment by Application
2.3.1 Neoplastic Diseases
2.3.2 Blood Disorders
2.3.3 Others
2.3.4 G-CSF Injection Sales by Application
2.3.4.1 Global G-CSF Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global G-CSF Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global G-CSF Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global G-CSF Injection Breakdown Data by Company
3.1.1 Global G-CSF Injection Annual Sales by Company (2021-2026)
3.1.2 Global G-CSF Injection Sales Market Share by Company (2021-2026)
3.2 Global G-CSF Injection Annual Revenue by Company (2021-2026)
3.2.1 Global G-CSF Injection Revenue by Company (2021-2026)
3.2.2 Global G-CSF Injection Revenue Market Share by Company (2021-2026)
3.3 Global G-CSF Injection Sale Price by Company
3.4 Key Manufacturers G-CSF Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers G-CSF Injection Product Location Distribution
3.4.2 Players G-CSF Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR G-CSF INJECTION BY GEOGRAPHIC REGION
4.1 World Historic G-CSF Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global G-CSF Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global G-CSF Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic G-CSF Injection Market Size by Country/Region (2021-2026)
4.2.1 Global G-CSF Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global G-CSF Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas G-CSF Injection Sales Growth
4.4 APAC G-CSF Injection Sales Growth
4.5 Europe G-CSF Injection Sales Growth
4.6 Middle East & Africa G-CSF Injection Sales Growth
5 AMERICAS
5.1 Americas G-CSF Injection Sales by Country
5.1.1 Americas G-CSF Injection Sales by Country (2021-2026)
5.1.2 Americas G-CSF Injection Revenue by Country (2021-2026)
5.2 Americas G-CSF Injection Sales by Type (2021-2026)
5.3 Americas G-CSF Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC G-CSF Injection Sales by Region
6.1.1 APAC G-CSF Injection Sales by Region (2021-2026)
6.1.2 APAC G-CSF Injection Revenue by Region (2021-2026)
6.2 APAC G-CSF Injection Sales by Type (2021-2026)
6.3 APAC G-CSF Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe G-CSF Injection by Country
7.1.1 Europe G-CSF Injection Sales by Country (2021-2026)
7.1.2 Europe G-CSF Injection Revenue by Country (2021-2026)
7.2 Europe G-CSF Injection Sales by Type (2021-2026)
7.3 Europe G-CSF Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa G-CSF Injection by Country
8.1.1 Middle East & Africa G-CSF Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa G-CSF Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa G-CSF Injection Sales by Type (2021-2026)
8.3 Middle East & Africa G-CSF Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of G-CSF Injection
10.3 Manufacturing Process Analysis of G-CSF Injection
10.4 Industry Chain Structure of G-CSF Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 G-CSF Injection Distributors
11.3 G-CSF Injection Customer
12 WORLD FORECAST REVIEW FOR G-CSF INJECTION BY GEOGRAPHIC REGION
12.1 Global G-CSF Injection Market Size Forecast by Region
12.1.1 Global G-CSF Injection Forecast by Region (2027-2032)
12.1.2 Global G-CSF Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global G-CSF Injection Forecast by Type (2027-2032)
12.7 Global G-CSF Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. G-CSF Injection Product Portfolios and Specifications
13.1.3 Amgen Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer G-CSF Injection Product Portfolios and Specifications
13.2.3 Pfizer G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Sandoz (Novartis)
13.3.1 Sandoz (Novartis) Company Information
13.3.2 Sandoz (Novartis) G-CSF Injection Product Portfolios and Specifications
13.3.3 Sandoz (Novartis) G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sandoz (Novartis) Main Business Overview
13.3.5 Sandoz (Novartis) Latest Developments
13.4 Spectrum Pharmaceuticals
13.4.1 Spectrum Pharmaceuticals Company Information
13.4.2 Spectrum Pharmaceuticals G-CSF Injection Product Portfolios and Specifications
13.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Spectrum Pharmaceuticals Main Business Overview
13.4.5 Spectrum Pharmaceuticals Latest Developments
13.5 Biocon Biologics Inc.
13.5.1 Biocon Biologics Inc. Company Information
13.5.2 Biocon Biologics Inc. G-CSF Injection Product Portfolios and Specifications
13.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Biologics Inc. Main Business Overview
13.5.5 Biocon Biologics Inc. Latest Developments
13.6 Coherus BioSciences, Inc.
13.6.1 Coherus BioSciences, Inc. Company Information
13.6.2 Coherus BioSciences, Inc. G-CSF Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences, Inc. Main Business Overview
13.6.5 Coherus BioSciences, Inc. Latest Developments
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Information
13.7.2 Teva Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceutical Main Business Overview
13.7.5 Teva Pharmaceutical Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi G-CSF Injection Product Portfolios and Specifications
13.8.3 Sanofi G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Yifan Pharmaceutical
13.9.1 Yifan Pharmaceutical Company Information
13.9.2 Yifan Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Yifan Pharmaceutical Main Business Overview
13.9.5 Yifan Pharmaceutical Latest Developments
13.10 CSPC
13.10.1 CSPC Company Information
13.10.2 CSPC G-CSF Injection Product Portfolios and Specifications
13.10.3 CSPC G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CSPC Main Business Overview
13.10.5 CSPC Latest Developments
13.11 Jiangsu Hengrui Medicine
13.11.1 Jiangsu Hengrui Medicine Company Information
13.11.2 Jiangsu Hengrui Medicine G-CSF Injection Product Portfolios and Specifications
13.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Hengrui Medicine Main Business Overview
13.11.5 Jiangsu Hengrui Medicine Latest Developments
13.12 Qilu Pharmaceutical
13.12.1 Qilu Pharmaceutical Company Information
13.12.2 Qilu Pharmaceutical G-CSF Injection Product Portfolios and Specifications
13.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Qilu Pharmaceutical Main Business Overview
13.12.5 Qilu Pharmaceutical Latest Developments
13.13 Shan Dong Kexing Biopharm
13.13.1 Shan Dong Kexing Biopharm Company Information
13.13.2 Shan Dong Kexing Biopharm G-CSF Injection Product Portfolios and Specifications
13.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shan Dong Kexing Biopharm Main Business Overview
13.13.5 Shan Dong Kexing Biopharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. G-CSF Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. G-CSF Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-acting G-CSF Injection
Table 4. Major Players of Short-acting G-CSF Injection
Table 5. Global G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global G-CSF Injection Sales Market Share by Type (2021-2026)
Table 7. Global G-CSF Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global G-CSF Injection Revenue Market Share by Type (2021-2026)
Table 9. Global G-CSF Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global G-CSF Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global G-CSF Injection Sale Market Share by Application (2021-2026)
Table 12. Global G-CSF Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global G-CSF Injection Revenue Market Share by Application (2021-2026)
Table 14. Global G-CSF Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global G-CSF Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global G-CSF Injection Sales Market Share by Company (2021-2026)
Table 17. Global G-CSF Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global G-CSF Injection Revenue Market Share by Company (2021-2026)
Table 19. Global G-CSF Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers G-CSF Injection Producing Area Distribution and Sales Area
Table 21. Players G-CSF Injection Products Offered
Table 22. G-CSF Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global G-CSF Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global G-CSF Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global G-CSF Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global G-CSF Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global G-CSF Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global G-CSF Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global G-CSF Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global G-CSF Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas G-CSF Injection Sales Market Share by Country (2021-2026)
Table 35. Americas G-CSF Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC G-CSF Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC G-CSF Injection Sales Market Share by Region (2021-2026)
Table 40. APAC G-CSF Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe G-CSF Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa G-CSF Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of G-CSF Injection
Table 52. Key Market Challenges & Risks of G-CSF Injection
Table 53. Key Industry Trends of G-CSF Injection
Table 54. G-CSF Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. G-CSF Injection Distributors List
Table 57. G-CSF Injection Customer List
Table 58. Global G-CSF Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global G-CSF Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas G-CSF Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC G-CSF Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC G-CSF Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe G-CSF Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa G-CSF Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global G-CSF Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global G-CSF Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global G-CSF Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global G-CSF Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Inc. G-CSF Injection Product Portfolios and Specifications
Table 74. Amgen Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Inc. Main Business
Table 76. Amgen Inc. Latest Developments
Table 77. Pfizer Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer G-CSF Injection Product Portfolios and Specifications
Table 79. Pfizer G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Sandoz (Novartis) Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz (Novartis) G-CSF Injection Product Portfolios and Specifications
Table 84. Sandoz (Novartis) G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sandoz (Novartis) Main Business
Table 86. Sandoz (Novartis) Latest Developments
Table 87. Spectrum Pharmaceuticals Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Spectrum Pharmaceuticals G-CSF Injection Product Portfolios and Specifications
Table 89. Spectrum Pharmaceuticals G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Spectrum Pharmaceuticals Main Business
Table 91. Spectrum Pharmaceuticals Latest Developments
Table 92. Biocon Biologics Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Biocon Biologics Inc. G-CSF Injection Product Portfolios and Specifications
Table 94. Biocon Biologics Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Biocon Biologics Inc. Main Business
Table 96. Biocon Biologics Inc. Latest Developments
Table 97. Coherus BioSciences, Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Coherus BioSciences, Inc. G-CSF Injection Product Portfolios and Specifications
Table 99. Coherus BioSciences, Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Coherus BioSciences, Inc. Main Business
Table 101. Coherus BioSciences, Inc. Latest Developments
Table 102. Teva Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 104. Teva Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceutical Main Business
Table 106. Teva Pharmaceutical Latest Developments
Table 107. Sanofi Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi G-CSF Injection Product Portfolios and Specifications
Table 109. Sanofi G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Yifan Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Yifan Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 114. Yifan Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Yifan Pharmaceutical Main Business
Table 116. Yifan Pharmaceutical Latest Developments
Table 117. CSPC Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. CSPC G-CSF Injection Product Portfolios and Specifications
Table 119. CSPC G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. CSPC Main Business
Table 121. CSPC Latest Developments
Table 122. Jiangsu Hengrui Medicine Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Hengrui Medicine G-CSF Injection Product Portfolios and Specifications
Table 124. Jiangsu Hengrui Medicine G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Hengrui Medicine Main Business
Table 126. Jiangsu Hengrui Medicine Latest Developments
Table 127. Qilu Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qilu Pharmaceutical Main Business
Table 131. Qilu Pharmaceutical Latest Developments
Table 132. Shan Dong Kexing Biopharm Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Shan Dong Kexing Biopharm G-CSF Injection Product Portfolios and Specifications
Table 134. Shan Dong Kexing Biopharm G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shan Dong Kexing Biopharm Main Business
Table 136. Shan Dong Kexing Biopharm Latest Developments
Table 1. G-CSF Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. G-CSF Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-acting G-CSF Injection
Table 4. Major Players of Short-acting G-CSF Injection
Table 5. Global G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global G-CSF Injection Sales Market Share by Type (2021-2026)
Table 7. Global G-CSF Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global G-CSF Injection Revenue Market Share by Type (2021-2026)
Table 9. Global G-CSF Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global G-CSF Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global G-CSF Injection Sale Market Share by Application (2021-2026)
Table 12. Global G-CSF Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global G-CSF Injection Revenue Market Share by Application (2021-2026)
Table 14. Global G-CSF Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global G-CSF Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global G-CSF Injection Sales Market Share by Company (2021-2026)
Table 17. Global G-CSF Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global G-CSF Injection Revenue Market Share by Company (2021-2026)
Table 19. Global G-CSF Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers G-CSF Injection Producing Area Distribution and Sales Area
Table 21. Players G-CSF Injection Products Offered
Table 22. G-CSF Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global G-CSF Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global G-CSF Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global G-CSF Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global G-CSF Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global G-CSF Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global G-CSF Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global G-CSF Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global G-CSF Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas G-CSF Injection Sales Market Share by Country (2021-2026)
Table 35. Americas G-CSF Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC G-CSF Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC G-CSF Injection Sales Market Share by Region (2021-2026)
Table 40. APAC G-CSF Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe G-CSF Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa G-CSF Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa G-CSF Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa G-CSF Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa G-CSF Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of G-CSF Injection
Table 52. Key Market Challenges & Risks of G-CSF Injection
Table 53. Key Industry Trends of G-CSF Injection
Table 54. G-CSF Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. G-CSF Injection Distributors List
Table 57. G-CSF Injection Customer List
Table 58. Global G-CSF Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global G-CSF Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas G-CSF Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC G-CSF Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC G-CSF Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe G-CSF Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa G-CSF Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa G-CSF Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global G-CSF Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global G-CSF Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global G-CSF Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global G-CSF Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Inc. G-CSF Injection Product Portfolios and Specifications
Table 74. Amgen Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Inc. Main Business
Table 76. Amgen Inc. Latest Developments
Table 77. Pfizer Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer G-CSF Injection Product Portfolios and Specifications
Table 79. Pfizer G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Sandoz (Novartis) Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz (Novartis) G-CSF Injection Product Portfolios and Specifications
Table 84. Sandoz (Novartis) G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sandoz (Novartis) Main Business
Table 86. Sandoz (Novartis) Latest Developments
Table 87. Spectrum Pharmaceuticals Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Spectrum Pharmaceuticals G-CSF Injection Product Portfolios and Specifications
Table 89. Spectrum Pharmaceuticals G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Spectrum Pharmaceuticals Main Business
Table 91. Spectrum Pharmaceuticals Latest Developments
Table 92. Biocon Biologics Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Biocon Biologics Inc. G-CSF Injection Product Portfolios and Specifications
Table 94. Biocon Biologics Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Biocon Biologics Inc. Main Business
Table 96. Biocon Biologics Inc. Latest Developments
Table 97. Coherus BioSciences, Inc. Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Coherus BioSciences, Inc. G-CSF Injection Product Portfolios and Specifications
Table 99. Coherus BioSciences, Inc. G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Coherus BioSciences, Inc. Main Business
Table 101. Coherus BioSciences, Inc. Latest Developments
Table 102. Teva Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 104. Teva Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceutical Main Business
Table 106. Teva Pharmaceutical Latest Developments
Table 107. Sanofi Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi G-CSF Injection Product Portfolios and Specifications
Table 109. Sanofi G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Yifan Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Yifan Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 114. Yifan Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Yifan Pharmaceutical Main Business
Table 116. Yifan Pharmaceutical Latest Developments
Table 117. CSPC Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. CSPC G-CSF Injection Product Portfolios and Specifications
Table 119. CSPC G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. CSPC Main Business
Table 121. CSPC Latest Developments
Table 122. Jiangsu Hengrui Medicine Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Hengrui Medicine G-CSF Injection Product Portfolios and Specifications
Table 124. Jiangsu Hengrui Medicine G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jiangsu Hengrui Medicine Main Business
Table 126. Jiangsu Hengrui Medicine Latest Developments
Table 127. Qilu Pharmaceutical Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical G-CSF Injection Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Qilu Pharmaceutical Main Business
Table 131. Qilu Pharmaceutical Latest Developments
Table 132. Shan Dong Kexing Biopharm Basic Information, G-CSF Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Shan Dong Kexing Biopharm G-CSF Injection Product Portfolios and Specifications
Table 134. Shan Dong Kexing Biopharm G-CSF Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shan Dong Kexing Biopharm Main Business
Table 136. Shan Dong Kexing Biopharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of G-CSF Injection
Figure 2. G-CSF Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global G-CSF Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global G-CSF Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. G-CSF Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. G-CSF Injection Sales Market Share by Country/Region (2025)
Figure 10. G-CSF Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-acting G-CSF Injection
Figure 12. Product Picture of Short-acting G-CSF Injection
Figure 13. Global G-CSF Injection Sales Market Share by Type in 2026
Figure 14. Global G-CSF Injection Revenue Market Share by Type (2021-2026)
Figure 15. G-CSF Injection Consumed in Neoplastic Diseases
Figure 16. Global G-CSF Injection Market: Neoplastic Diseases (2021-2026) & (K Units)
Figure 17. G-CSF Injection Consumed in Blood Disorders
Figure 18. Global G-CSF Injection Market: Blood Disorders (2021-2026) & (K Units)
Figure 19. G-CSF Injection Consumed in Others
Figure 20. Global G-CSF Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global G-CSF Injection Sale Market Share by Application (2025)
Figure 22. Global G-CSF Injection Revenue Market Share by Application in 2026
Figure 23. G-CSF Injection Sales by Company in 2026 (K Units)
Figure 24. Global G-CSF Injection Sales Market Share by Company in 2026
Figure 25. G-CSF Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global G-CSF Injection Revenue Market Share by Company in 2026
Figure 27. Global G-CSF Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global G-CSF Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas G-CSF Injection Sales 2021-2026 (K Units)
Figure 30. Americas G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC G-CSF Injection Sales 2021-2026 (K Units)
Figure 32. APAC G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe G-CSF Injection Sales 2021-2026 (K Units)
Figure 34. Europe G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa G-CSF Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas G-CSF Injection Sales Market Share by Country in 2026
Figure 38. Americas G-CSF Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 41. United States G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC G-CSF Injection Sales Market Share by Region in 2026
Figure 46. APAC G-CSF Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 49. China G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe G-CSF Injection Sales Market Share by Country in 2026
Figure 57. Europe G-CSF Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa G-CSF Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of G-CSF Injection in 2026
Figure 74. Manufacturing Process Analysis of G-CSF Injection
Figure 75. Industry Chain Structure of G-CSF Injection
Figure 76. Channels of Distribution
Figure 77. Global G-CSF Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global G-CSF Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global G-CSF Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global G-CSF Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global G-CSF Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global G-CSF Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of G-CSF Injection
Figure 2. G-CSF Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global G-CSF Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global G-CSF Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. G-CSF Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. G-CSF Injection Sales Market Share by Country/Region (2025)
Figure 10. G-CSF Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-acting G-CSF Injection
Figure 12. Product Picture of Short-acting G-CSF Injection
Figure 13. Global G-CSF Injection Sales Market Share by Type in 2026
Figure 14. Global G-CSF Injection Revenue Market Share by Type (2021-2026)
Figure 15. G-CSF Injection Consumed in Neoplastic Diseases
Figure 16. Global G-CSF Injection Market: Neoplastic Diseases (2021-2026) & (K Units)
Figure 17. G-CSF Injection Consumed in Blood Disorders
Figure 18. Global G-CSF Injection Market: Blood Disorders (2021-2026) & (K Units)
Figure 19. G-CSF Injection Consumed in Others
Figure 20. Global G-CSF Injection Market: Others (2021-2026) & (K Units)
Figure 21. Global G-CSF Injection Sale Market Share by Application (2025)
Figure 22. Global G-CSF Injection Revenue Market Share by Application in 2026
Figure 23. G-CSF Injection Sales by Company in 2026 (K Units)
Figure 24. Global G-CSF Injection Sales Market Share by Company in 2026
Figure 25. G-CSF Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global G-CSF Injection Revenue Market Share by Company in 2026
Figure 27. Global G-CSF Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global G-CSF Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas G-CSF Injection Sales 2021-2026 (K Units)
Figure 30. Americas G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC G-CSF Injection Sales 2021-2026 (K Units)
Figure 32. APAC G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe G-CSF Injection Sales 2021-2026 (K Units)
Figure 34. Europe G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa G-CSF Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa G-CSF Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas G-CSF Injection Sales Market Share by Country in 2026
Figure 38. Americas G-CSF Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 41. United States G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC G-CSF Injection Sales Market Share by Region in 2026
Figure 46. APAC G-CSF Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 49. China G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe G-CSF Injection Sales Market Share by Country in 2026
Figure 57. Europe G-CSF Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa G-CSF Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa G-CSF Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa G-CSF Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries G-CSF Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of G-CSF Injection in 2026
Figure 74. Manufacturing Process Analysis of G-CSF Injection
Figure 75. Industry Chain Structure of G-CSF Injection
Figure 76. Channels of Distribution
Figure 77. Global G-CSF Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global G-CSF Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global G-CSF Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global G-CSF Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global G-CSF Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global G-CSF Injection Revenue Market Share Forecast by Application (2027-2032)
